covid 19 News and Research

RSS

Male hypogonadism associated with risk of hospitalization for COVID-19

Men with low testosterone levels are more likely to require hospitalization after COVID-19 infection than men with normal levels or those on testosterone therapy, according to Saint Louis University School of Medicine and Washington University School of Medicine in St. Louis researchers.

2 Sep 2022

Covid-19 study highlights a continued drop in U.S. life expectancy

An updated analysis of American COVID-19 deaths throughout 2021 highlights a continued drop in overall life expectancy as well as persistent disparities by race and ethnicity.

2 Sep 2022

COVID has changed people's perception of natural spaces

The pandemic has impacted our lives in a multitude of ways, many of which will no doubt be felt for years to come.

2 Sep 2022

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

Millions of people have died of coronavirus infection since 2020 because influential institutions took too long to recognize that it is primarily airborne, and a new University of Colorado Boulder-led historical analysis sheds light on the delay.

2 Sep 2022

Study uncovers the evolutionary dynamics of SARS-CoV-2 at primary stage of massive vaccination

This study uncovers the evolutionary dynamics of SARS-CoV-2 and epidemiological characteristics of COVID-19 at the primary stage of massive vaccination

2 Sep 2022

Men with low testosterone may have higher risk of COVID-19 hospitalization

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine in St. Louis and Saint Louis University School of Medicine.

2 Sep 2022

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Researchers summarized existing data on the immunogenicity of COVID-19 vaccines and the humoral and cellular immune responses against SARS-CoV-2.

2 Sep 2022

What is the risk of BA.5 infection among persons with documented infection with past variants?

A recent correspondence discussed a study in which researchers assessed the infection risk for the SARS-CoV-2 Omicron BA.5 subvariant in vaccinated people exposed to previous SARS-CoV-2 variants.

2 Sep 2022

Study provides important clues for protecting frogs from lethal Bd infection

As the globe continues to battle COVID-19, another pandemic – the deadly fungus Batrachochytrium dendrobatidis (Bd) - is ravaging the world’s frog species, contributing to the instability of Earth’s delicate ecosystem.

2 Sep 2022

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

Researchers presented findings from the second version of a living systematic review on long COVID.

2 Sep 2022

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

2 Sep 2022

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Researchers assessed the impact of COVID-19 infection on B-cell and antibody responses to COVID-19 booster vaccination.

2 Sep 2022

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

In a recent JAMA Pediatrics study, scientists analyzed a cohort containing children and adolescents after recovering from COVID-19 to determine the dynamics of neutralizing antibodies.

2 Sep 2022

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

A recent PLoS ONE study detected neutralizing nanobodies against SARS-CoV-2 from nanobody phage display libraries and via in vitro and ex vivo high-throughput screenings.

2 Sep 2022

CDC recommends Novavax's COVID-19 vaccine to be used as primary series option for adolescents

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax's COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.

1 Sep 2022

New substance boosts the effect of protein-based COVID-19 vaccines

Ironically, some vaccines need their own "boosters." Adding an ingredient called an adjuvant can help vaccines elicit a more robust immune response, better training the body to fight a pathogen.

1 Sep 2022

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

In a new study, researchers illustrated that metformin was associated with decreased coronavirus disease 2019 (COVID-19) severity among prediabetic patients.

1 Sep 2022

What is the influence of individual infectiousness variation on COVID-19 spread across households?

In a new study, scientists characterized the effect of individual infectiousness variance on the transmission heterogeneity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among households.

1 Sep 2022

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

The current study focused on the ability of this nmAb to neutralize Delta, Omicron, and other VOCs, as well as its efficacy when given by the intranasal route in an animal model.

1 Sep 2022

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

covid 19 News and Research

Male hypogonadism associated with risk of hospitalization for COVID-19

Covid-19 study highlights a continued drop in U.S. life expectancy

COVID has changed people's perception of natural spaces

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

Study uncovers the evolutionary dynamics of SARS-CoV-2 at primary stage of massive vaccination

Men with low testosterone may have higher risk of COVID-19 hospitalization

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

What is the risk of BA.5 infection among persons with documented infection with past variants?

Study provides important clues for protecting frogs from lethal Bd infection

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

The origins, breadth, and resolution of autoreactivity in severe COVID-19

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

CDC recommends Novavax's COVID-19 vaccine to be used as primary series option for adolescents

New substance boosts the effect of protein-based COVID-19 vaccines

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

What is the influence of individual infectiousness variation on COVID-19 spread across households?

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

How does origin impact antiviral immune response?

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News